This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Choi, Y. Articles by Tung, C.-H. Search for Related Content PubMed PubMed Citation Articles by Choi, Y. Articles by Tung, C.-H.

Selective Antitumor Effect of Novel Protease-Mediated Photodynamic Agent

Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts

Requests for reprints: Ching-Hsuan Tung, Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, 149, 13th Street, Room 5406, Charlestown, MA 02129. Phone: 617-726-5779; Fax: 617-726-5708; E-mail: tung{at}helix.mgh.harvard.edu.

A new approach to selective photodynamic therapy (PDT) was developed by designing chlorin e6 (Ce6)–containing macromolecules, which are sensitive to tumor-associated proteases. The agents are nontoxic in their native state but become fluorescent and produce singlet oxygen on protease conversion. Coupled with optimized delivery systems, we show that (a) the agents efficiently accumulate in tumors due to the enhanced permeability and retention effect, (b) the agents are locally activated by proteases, (c) local drug concentrations can be measured by quantitative fluorescence tomography, and (d) light-treated tumors show reduced growth. A single low dose of PDT (0.125 mg Ce6 equivalent/kg) was sufficient to suppress tumor growth by >50%. Activatable singlet oxygen generation agents provide increased efficacy with reduced toxicity, and it could become a powerful PDT. (Cancer Res 2006; 66(14): 7225-9)

This article has been cited by other articles:

				G. Zheng, J. Chen, K. Stefflova, M. Jarvi, H. Li, and B. C. Wilson Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activation PNAS, May 22, 2007; 104(21): 8989 - 8994. [Abstract] [Full Text] [PDF]

				Y. Hama, Y. Urano, Y. Koyama, P. L. Choyke, and H. Kobayashi Activatable Fluorescent Molecular Imaging of Peritoneal Metastases following Pretargeting with a Biotinylated Monoclonal Antibody Cancer Res., April 15, 2007; 67(8): 3809 - 3817. [Abstract] [Full Text] [PDF]